Price movement over the last 24 hours
Agnico Eagle Mines Ltd vs Charles River Laboratories Intl. Inc — how do they compare? Agnico Eagle Mines Ltd trades at $145.36 (market cap $75.10B), while Charles River Laboratories Intl. Inc trades at $223.4 (market cap $11.01B). The key difference: Agnico Eagle Mines Ltd is far larger — about 6.8× Charles River Laboratories Intl. Inc's market cap, and Agnico Eagle Mines Ltd pays a 1.2% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| AEM | CRL | |
|---|---|---|
Market Cap | $75.10B | $11.01B |
Sector | Basic Materials | Health |
52-Week High | $252.19 | $231.43 |
52-Week Low | $116.14 | $145.57 |
Enterprise Value | $72.30B | $13.88B |
Dividend Yield | 1.2% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CRL trades at $228.68, down 0.87% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported negative net income of -$144.34M in 2025 despite revenue stability around $4.02B, resulting in a high P/E of 684.85. Recent earnings beats and strategic collaborations, such as with Lilly TuneLab (Business Wire, 2026-06-18), highlight operational strengths amid profitability challenges.
Outlook is mixed: strong analyst support (72% buy ratings) and positive cash flow trends contrast with negative margins and high debt. Key risks include sustained unprofitability and competitive pressures, but institutional confidence and technical momentum suggest potential for recovery if earnings improve.
Trailing returns across standard periods
Latest headlines on both assets
Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.
Read more on AEM →Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →